BofA/Merrill Lynch Starts Sagent Pharmaceuticals (SGNT) at Neutral
Tweet
Share
E-mailGet Alerts SGNT Hot Sheet
Price: $21.76 --0%
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 19
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 19
Join SI Premium – FREE
BofA/Merrill Lynch initiates coverage on Sagent Pharmaceuticals (NASDAQ: SGNT) with a Neutral. PT $27.
For more ratings news on Sagent Pharmaceuticals click here and for the rating history of Sagent Pharmaceuticals click here.
Shares of Sagent Pharmaceuticals closed at $25.21 yesterday.
For more ratings news on Sagent Pharmaceuticals click here and for the rating history of Sagent Pharmaceuticals click here.
Shares of Sagent Pharmaceuticals closed at $25.21 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Starts Warpaint London plc (W7L:LN) at Buy
- Mizuho Starts Regency Centers (REG) at Neutral
- Goldman Sachs Starts Hitachi Energy India Ltd (POWERIND:IN) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
